Track topics on Twitter Track topics that are important to you
NEW YORK, December 12, 2018 /PRNewswire/ -- IntSights Cyber Intelligence, the leading provider of surface, deep and dark web cyber threat intelligence and digital risk Read more...
Combines Powerful Analytics with Secure, Transparent Access and the Ability to Quickly Alert on Risky Privilege-Related Activity CyberArk (NASDAQ: CYBR), the glo...
Point Roberts, WA - November 15, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering defense and cybersecurity stocks releases a sector snapshot, following t...
Point Roberts, WA - November 16, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering defense and cybersecurity stocks releases a sector snapshot, following t...
Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...
CyberArk (NASDAQ: CYBR) is the global leader in privileged access security, a critical layer of IT security to protect data, infrastructure and assets across the ent...
We have published hundreds of CyberArk news stories on BioPortfolio along with dozens of CyberArk Clinical Trials and PubMed Articles about CyberArk for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CyberArk Companies in our database. You can also find out about relevant CyberArk Drugs and Medications on this site too.